Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Donor Specific Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03380377
What this trial is testing

Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant

Who this might be right for
Antibody-mediated RejectionKidney Transplant; ComplicationsTransplant Glomerulopathy+3 more
Stanley Jordan, MD 10
Post-approval studies (Phase 4)UnknownNCT04404127
What this trial is testing

Standard Induction With Basiliximab Versus No-Induction in Low Immunological Risk Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
King Faisal Specialist Hospital & Research Center 140
Not applicableStudy completedNCT06425497
What this trial is testing

DE NOVO DONOR SPECIFIC ANTIBODIES AFTER KIDNEY TRANSPLANTATION: SINGLE-CENTER RETROSPECTIVE STUDY

Who this might be right for
Kidney Transplant; ComplicationsImmunosuppression
University of Rome Tor Vergata 600
Post-approval studies (Phase 4)Active Not RecruitingNCT07274462
What this trial is testing

DARA-MVI Study (Daratumumab for Microvascular Inflammation in Kidney Transplantation)

Who this might be right for
Microvascular Inflammation - MVI in Kindey Transplant Recipients
University Hospital, Martin 20
Not applicableStudy completedNCT03438058
What this trial is testing

Complement-activating Anti-human Leucocyte Antigen Donor Specific Antibodies in Solid Organ Transplantation

Who this might be right for
Organ Transplant Recipients
Paris Translational Research Center for Organ Transplantation 7,547
Not applicableLooking for participantsNCT07134491
What this trial is testing

Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity

Who this might be right for
Antibody Mediated Rejection After Kidney Transplantation
Assistance Publique - Hôpitaux de Paris 45
Not applicableUnknownNCT03436134
What this trial is testing

Treatment of Chronic Active Antibody Mediated Rejection After Kidney Transplantation by Double-Filtration PlasmaPheresis or Plasma Exchange

Who this might be right for
Kidney TransplantationAntibody Mediated Rejection
University Hospital, Grenoble 16
Not applicableEnded earlyNCT02133248
What this trial is testing

Identification of Donor Specific B Cells and Antibody Mediated Rejection

Who this might be right for
Sensitized Kidney Transplant Recipients
University of Wisconsin, Madison 86
Not applicableLooking for participantsNCT06025240
What this trial is testing

Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients

Who this might be right for
Kidney TransplantRenal Transplant FailureKidney Transplant Rejection+5 more
Liverpool University Hospitals NHS Foundation Trust 282
Not applicableUnknownNCT05727709
What this trial is testing

Dynamic Changes of Torquetenovirus (TTV) Load in Chinese Renal Transplant Recipients

Who this might be right for
Kidney Transplant RejectionKidney Transplant InfectionVirus+1 more
Tongji Hospital 220
Early research (Phase 1)WithdrawnNCT00476515
What this trial is testing

Rituximab Therapy for Patients on Kidney Transplant Waiting List With Positive Donor Specific Crossmatch to Living Donor

Who this might be right for
Kidney Insufficiency
Massachusetts General Hospital
Post-approval studies (Phase 4)Study completedNCT02723591
What this trial is testing

To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Astellas Pharma Global Development, Inc. 599
Not applicableStudy completedNCT02752789
What this trial is testing

Impact of Allo- and Autoantibodies on Chronic Cardiac Allograft Function

Who this might be right for
Pediatric Heart TransplantationPediatric Heart Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 407
Testing effectiveness (Phase 2)Study completedNCT04779957
What this trial is testing

Evaluation of the Safety of Use of Anti-IL6 Receptor Antibodies to Reduce Allo-sensitization Post Allograft Nephrectomy

Who this might be right for
Kidney TransplantationGraft Failure
University Hospital, Toulouse 18
Large-scale testing (Phase 3)Study completedNCT02013037
What this trial is testing

The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation

Who this might be right for
Antibody-mediated RejectionHyperacute Rejection of Cardiac TransplantLeft Ventricular Dysfunction+2 more
Cedars-Sinai Medical Center 36
Large-scale testing (Phase 3)Active Not RecruitingNCT04561986
What this trial is testing

TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients

Who this might be right for
Antibody-mediated Rejection
Vastra Gotaland Region 50
Very early researchEnded earlyNCT03380936
What this trial is testing

Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
University of Colorado, Denver 4
Not applicableStudy completedNCT03238443
What this trial is testing

Interest of the Donor-specific Antibodies After Liver Transplantation

Who this might be right for
Liver Transplant
University Hospital, Lille 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07698080
What this trial is testing

Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaThalassemia+2 more
Hematology department of the 920th hospital 60
Not applicableUnknownNCT03861962
What this trial is testing

Re-evaluation of Donor-specific Anti-HLA Alloantibodies Immunoassay After Organ Transplantation, From Antigen Level to Epitope Level

Who this might be right for
Organ Transplantation
Assistance Publique - Hôpitaux de Paris 20,000
Next Page